CLINICAL_TRIALS trial_result · 2013-10-23

Clinical Trial Update: Study of MAP0010 in Asthmatic Children and Adolescents [Phase 2]

A Phase 2 trial evaluating MAP0010 in asthmatic children and adolescents has completed. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Allergan | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-10-23